SOFIA (Bulgaria), September 28 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Monday that its CEO Ognyan Donev further increased his interest in the company through a transaction on the regulated market of the Bulgarian Stock Exchange on September 25.